PubMed (RefSeq) for id: 218563730

Year	Number of Results
1988	1
1995	1
1996	1
1998	4
1999	3
2000	7
2001	6
2002	12
2003	15
2004	15
2005	16
2006	16
2007	12
2008	17
2009	14
2010	24
2011	20
2012	15
2013	14
2014	18
2015	17
2016	17
2017	15
2018	12
2019	18
2020	21
2021	19
2022	10
2023	7
2024	3

1

Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.

Wang K, Wu J, Yang Z, Zheng B, Shen S, Wang RR, Zhang Y, Wang HY, Chen L, Qiu X. Wang K, et al. Cancer Lett. 2024 Apr 1;586:216690. doi: 10.1016/j.canlet.2024.216690. Epub 2024 Feb 1. Cancer Lett. 2024. PMID: 38307410 Free article.

2

The CXCL10-CXCR3 axis plays an important role in Kawasaki disease.

Hosaka S, Imagawa K, Yano Y, Lin L, Shiono J, Takahashi-Igari M, Hara H, Hayashi D, Imai H, Morita A, Fukushima H, Takada H. Hosaka S, et al. Clin Exp Immunol. 2024 Mar 12;216(1):104-111. doi: 10.1093/cei/uxad125. Clin Exp Immunol. 2024. PMID: 37952216

3

The IFN-γ-CXCL9/CXCL10-CXCR3 axis in vitiligo: Pathological mechanism and treatment.

Liu H, Wang Y, Le Q, Tong J, Wang H. Liu H, et al. Eur J Immunol. 2024 Apr;54(4):e2250281. doi: 10.1002/eji.202250281. Epub 2024 Mar 5. Eur J Immunol. 2024. PMID: 37937817 Review.

4

CXCL9 and its Receptor CXCR3, an Important Link Between Inflammation and Cardiovascular Risks in RA Patients.

Shamsi A, Roghani SA, Abdan Z, Soufivand P, Pournazari M, Bahrehmand F, Vafaei A, Salari N, Soroush MG, Taghadosi M. Shamsi A, et al. Inflammation. 2023 Dec;46(6):2374-2385. doi: 10.1007/s10753-023-01884-5. Epub 2023 Aug 5. Inflammation. 2023. PMID: 37542661

5

EBV-positive pyothorax-associated lymphoma expresses CXCL9 and CXCL10 chemokines that attract cytotoxic lymphocytes via CXCR3.

Higuchi T, Hashida Y, Matsuo K, Kitahata K, Ujihara T, Murakami I, Nakayama T, Daibata M. Higuchi T, et al. Cancer Sci. 2023 Jun;114(6):2622-2633. doi: 10.1111/cas.15782. Epub 2023 Mar 20. Cancer Sci. 2023. PMID: 36898851 Free PMC article.

6

CXCR3 predicts the prognosis of endometrial adenocarcinoma.

Dong H, Sun M, Li H, Yue Y. Dong H, et al. BMC Med Genomics. 2023 Feb 7;16(1):20. doi: 10.1186/s12920-023-01451-9. BMC Med Genomics. 2023. PMID: 36750966 Free PMC article.

7

Clinical Significance of the Pre-Transplant CXCR3 and CCR6 Expression on T Cells In Kidney Graft Recipients.

Alfaro R, Llorente S, Gonzalez-Martínez G, Jimenez-Coll V, Martínez-Banaclocha H, Galián JA, Botella C, Moya-Quiles MR, de la Peña-Moral J, Minguela A, Legaz I, Muro M. Alfaro R, et al. Transplant Proc. 2023 Jan-Feb;55(1):66-71. doi: 10.1016/j.transproceed.2022.12.012. Epub 2023 Jan 6. Transplant Proc. 2023. PMID: 36621349 Free article.

8

Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma.

Takashima Y, Hamano M, Yoshii K, Hayano A, Fukai J, Iwadate Y, Kajiwara K, Hondoh H, Yamanaka R. Takashima Y, et al. Int J Clin Oncol. 2023 Mar;28(3):468-481. doi: 10.1007/s10147-022-02285-8. Epub 2023 Jan 6. Int J Clin Oncol. 2023. PMID: 36607476

9

Relationship between dry eye and expressions of CXCR3 and CCR5 after ocular acid burn.

Jiang B, Hu Q, Li T, She M, Li C, Zhou X. Jiang B, et al. BMC Ophthalmol. 2022 Dec 15;22(1):489. doi: 10.1186/s12886-022-02678-3. BMC Ophthalmol. 2022. PMID: 36522768 Free PMC article.

10

IL-2/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K/AKT and ERK1/2 pathways.

Liu L, Cheng Y, Zhang F, Chen J, Tian P, Shi W, Zhou F, Yang M, Zhou M, Liu B. Liu L, et al. J Cancer Res Clin Oncol. 2023 Aug;149(9):5547-5557. doi: 10.1007/s00432-022-04509-w. Epub 2022 Dec 6. J Cancer Res Clin Oncol. 2023. PMID: 36474002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

335 results

Results by year